DK115581A - Fremgangsmaade til fremstilling af pyrimidylquinazoliner - Google Patents

Fremgangsmaade til fremstilling af pyrimidylquinazoliner

Info

Publication number
DK115581A
DK115581A DK115581A DK115581A DK115581A DK 115581 A DK115581 A DK 115581A DK 115581 A DK115581 A DK 115581A DK 115581 A DK115581 A DK 115581A DK 115581 A DK115581 A DK 115581A
Authority
DK
Denmark
Prior art keywords
pyrimidylquinazolines
preparing
preparing pyrimidylquinazolines
Prior art date
Application number
DK115581A
Other languages
English (en)
Inventor
H Bender
T Raabe
H Bohn
P Martorana
Original Assignee
Cassella Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Ag filed Critical Cassella Ag
Publication of DK115581A publication Critical patent/DK115581A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Catching Or Destruction (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK115581A 1980-03-27 1981-03-13 Fremgangsmaade til fremstilling af pyrimidylquinazoliner DK115581A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803011809 DE3011809A1 (de) 1980-03-27 1980-03-27 Pyrimidyl-chinazoline, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und ihre verwendung

Publications (1)

Publication Number Publication Date
DK115581A true DK115581A (da) 1981-09-28

Family

ID=6098481

Family Applications (1)

Application Number Title Priority Date Filing Date
DK115581A DK115581A (da) 1980-03-27 1981-03-13 Fremgangsmaade til fremstilling af pyrimidylquinazoliner

Country Status (18)

Country Link
EP (1) EP0037495A1 (da)
JP (1) JPS56150088A (da)
AR (1) AR227542A1 (da)
AU (1) AU6877481A (da)
CA (1) CA1156656A (da)
CS (1) CS219898B2 (da)
DD (1) DD157614A5 (da)
DE (1) DE3011809A1 (da)
DK (1) DK115581A (da)
ES (1) ES8202000A1 (da)
FI (1) FI810778A7 (da)
GR (1) GR71870B (da)
IL (1) IL62495A0 (da)
NO (1) NO810870L (da)
PL (2) PL230320A1 (da)
PT (1) PT72724B (da)
SU (1) SU1052158A3 (da)
ZA (1) ZA812034B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61140568A (ja) * 1984-12-14 1986-06-27 Mitsui Petrochem Ind Ltd キナゾリン誘導体及びそれを有効成分とする血圧降下剤
JPS6267077A (ja) * 1985-09-18 1987-03-26 Mitsui Petrochem Ind Ltd キナゾリン誘導体及び医薬
CN102079743B (zh) * 2004-03-15 2020-08-25 武田药品工业株式会社 二肽基肽酶抑制剂
US7576076B2 (en) * 2004-07-02 2009-08-18 Corcept Therapeutics, Inc. Modified pyrimidine glucocorticoid receptor modulators
CN103596431B (zh) 2011-03-18 2016-06-22 科赛普特治疗公司 嘧啶环己基糖皮质激素受体调节剂
CA3102099C (en) 2018-06-04 2023-09-26 Corcept Therapeutics Incorporated Pyrimidine cyclohexenyl glucocorticoid receptor modulators
JP7569492B2 (ja) 2019-12-11 2024-10-18 コーセプト セラピューティクス， インコーポレイテッド 抗精神病薬誘発性体重増加のミリコリラントによる治療方法
KR102911885B1 (ko) 2020-05-06 2026-01-12 코어셉트 쎄라퓨틱스 인코포레이티드 피리미딘 사이클로헥실 글루코코르티코이드 수용체 조절제의 다형체
AU2021266739B2 (en) 2020-05-06 2024-11-28 Corcept Therapeutics Incorporated Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators
JP7853982B2 (ja) 2020-12-21 2026-04-30 コーセプト セラピューティクス， インコーポレイテッド ピリミジンシクロヘキシルグルココルチコイド受容体調節因子を調製する方法
US12616698B2 (en) 2021-05-05 2026-05-05 Corcept Therapeutics Incorporated Methods for reducing liver fat and for treating fatty liver disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2007656B (en) * 1977-11-05 1982-05-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
SU1052158A3 (ru) 1983-10-30
PT72724B (de) 1982-03-24
ZA812034B (en) 1982-05-26
IL62495A0 (en) 1981-05-20
CS219898B2 (en) 1983-03-25
AU6877481A (en) 1981-10-01
PL233882A1 (da) 1982-05-10
FI810778L (fi) 1981-09-28
FI810778A7 (fi) 1981-09-28
EP0037495A1 (de) 1981-10-14
DD157614A5 (de) 1982-11-24
JPS56150088A (en) 1981-11-20
DE3011809A1 (de) 1981-10-01
ES500738A0 (es) 1982-01-16
PL230320A1 (da) 1982-03-29
ES8202000A1 (es) 1982-01-16
GR71870B (da) 1983-07-08
NO810870L (no) 1981-09-28
AR227542A1 (es) 1982-11-15
CA1156656A (en) 1983-11-08
PT72724A (de) 1981-04-01

Similar Documents

Publication Publication Date Title
DK280182A (da) Fremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
DK42480A (da) Fremgangsmaade til fremstilling af 1-aryl-2-acylamido-3-fluor-1-propanoler
DK606084D0 (da) Fremgangsmaade til fremstilling af 2-fluor-17beta-oestradiol
DK73381A (da) Fremgangsmaade til fremstilling af 3-iodmethylcephalosporiner
DK183583D0 (da) Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
DK224681A (da) Fremgangsmaade til fremstilling af diaet-oel
DK370582A (da) Fremgangsmaade til fremstilling af 2-beta-d-ribofuranosylthiazol-4-carboxamid
DK540781A (da) Fremgangsmaade til fremstilling af 2-hydronaphthalen-6-carboxylsyre
DK159309C (da) Fremgangsmaade til fremstilling af 4-metyl-5-alkylthiometyl-imidazoler
DK316981A (da) Fremgangsmaade til fremstilling af pentapeptider
DK369181A (da) Fremgangsmaade til fremstilling af triazolylvinylketonforbindelser
DK188881A (da) Fremgangsmaade til fremstilling af 2-guanidinthiazol-derivater
DK40883D0 (da) Fremgangsmade til fremstilling af benzothienylallylaminer
DK158312C (da) Fremgangsmaade til fremstilling af diacetoneketogulonsyre
DK449881A (da) Fremgangsmaade til fremstilling af moroxydinphenoxyisobutyrater
DK226881A (da) Fremgangsmaade til fremstilling af 3-picolin
DK399783A (da) Fremgangsmaade til fremstilling af substituerede 1-pyridyloxy-3-indolylalkylamino-2-propanoler
DK513580A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa (polyhalogenalkyl)-1h-imidazol-2-methanoler
DK71681A (da) Fremgangsmaade til fremstilling af piperidinokinazoliner
DK26881A (da) Fremgangsmaade til fremstilling af alfaketocarboxylsyre-n-tert. butylamider
DK362381A (da) Fremgangsmaade til fremstilling af polyazaheterocycliske fordelser
DK411881A (da) Fremgangsmaade til fremstilling af 1-oxa-beta-lactamantibiotika
DK380981A (da) Fremgangsmaade til fremstilling af benzoquinoliziner
DK400481A (da) Fremgangsmaade til fremstilling af 4-carbamoyloxy-oxazaphosporiner
DK432683D0 (da) Fremgangsmade til fremstilling af 2-hydroxy-2-phenylethylaminer

Legal Events

Date Code Title Description
ATS Application withdrawn